Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.
Meienberg
O
O
Roche Pharma, Reinach, Switzerland.
Amsler
F
F
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D020912:Moclobemide; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome
D000700:Analgesics; D001549:Benzamides; D020912:Moclobemide